Application 060304
- Type
- ANDA
- Sponsor
- TEVA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEOMYCIN SULFATE | NEOMYCIN SULFATE | TABLET;ORAL | 500MG | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A060304-001 | NEOMYCIN SULFATE | NEOMYCIN SULFATE | 500MG | TABLET / ORAL | AA | RS, Approved before 1982 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A060304-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A060304-001 | NEOMYCIN SULFATE | 500MG | TABLET / ORAL | AA | RS, Approved before 1982 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A060304-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Neomycin Sulfate | NEOMYCIN SULFATE | REMEDYREPACK INC. | 461f62b9-b9ec-43f2-aee7-0895638105b8 | 2026-04-24 | Boxed warning, Warnings, Adverse reactions | 060304 ANDA060304 |
| Neomycin Sulfate | NEOMYCIN SULFATE | Teva Pharmaceuticals USA, Inc. | 777dbfab-f83e-4738-ae1e-78619a9f82a7 | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | 060304 ANDA060304 0093-1177 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-1177 | Neomycin Sulfate | Neomycin Sulfate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-1177 | Neomycin Sulfate | Neomycin Sulfate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-1177 | Neomycin Sulfate | Neomycin Sulfate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-1177 | Neomycin Sulfate | Neomycin Sulfate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 63629-8352 | Neomycin Sulfate | Neomycin Sulfate | Bryant Ranch Prepack | ANDA | Current |
| 63629-8352 | Neomycin Sulfate | Neomycin Sulfate | Bryant Ranch Prepack | ANDA | Current |